These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 24886681)

  • 1. Peripheral vein infusion of autologous mesenchymal stem cells in Egyptian HCV-positive patients with end-stage liver disease.
    Salama H; Zekri AR; Medhat E; Al Alim SA; Ahmed OS; Bahnassy AA; Lotfy MM; Ahmed R; Musa S
    Stem Cell Res Ther; 2014 May; 5(3):70. PubMed ID: 24886681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of repeated autologous infusion of haematopoietic stem cells in patients with liver insufficiency.
    Zekri AR; Salama H; Medhat E; Musa S; Abdel-Haleem H; Ahmed OS; Khedr HA; Lotfy MM; Zachariah KS; Bahnassy AA
    Stem Cell Res Ther; 2015 Jun; 6(1):118. PubMed ID: 26062731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous hematopoietic stem cell transplantation in 48 patients with end-stage chronic liver diseases.
    Salama H; Zekri AR; Zern M; Bahnassy A; Loutfy S; Shalaby S; Vigen C; Burke W; Mostafa M; Medhat E; Alfi O; Huttinger E
    Cell Transplant; 2010; 19(11):1475-86. PubMed ID: 20587151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized placebo-controlled trial of mesenchymal stem cell transplantation in decompensated cirrhosis.
    Mohamadnejad M; Alimoghaddam K; Bagheri M; Ashrafi M; Abdollahzadeh L; Akhlaghpoor S; Bashtar M; Ghavamzadeh A; Malekzadeh R
    Liver Int; 2013 Nov; 33(10):1490-6. PubMed ID: 23763455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous mobilized peripheral blood CD34(+) cell infusion in non-viral decompensated liver cirrhosis.
    Sharma M; Rao PN; Sasikala M; Kuncharam MR; Reddy C; Gokak V; Raju B; Singh JR; Nag P; Nageshwar Reddy D
    World J Gastroenterol; 2015 Jun; 21(23):7264-71. PubMed ID: 26109814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. REpeated AutoLogous Infusions of STem cells In Cirrhosis (REALISTIC): a multicentre, phase II, open-label, randomised controlled trial of repeated autologous infusions of granulocyte colony-stimulating factor (GCSF) mobilised CD133+ bone marrow stem cells in patients with cirrhosis. A study protocol for a randomised controlled trial.
    King A; Barton D; Beard HA; Than N; Moore J; Corbett C; Thomas J; Guo K; Guha I; Hollyman D; Stocken D; Yap C; Fox R; Forbes SJ; Newsome PN
    BMJ Open; 2015 Mar; 5(3):e007700. PubMed ID: 25795699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous CD34+ and CD133+ stem cells transplantation in patients with end stage liver disease.
    Salama H; Zekri AR; Bahnassy AA; Medhat E; Halim HA; Ahmed OS; Mohamed G; Al Alim SA; Sherif GM
    World J Gastroenterol; 2010 Nov; 16(42):5297-305. PubMed ID: 21072892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advantages of adipose tissue stem cells over CD34
    De Luna-Saldivar MM; Marino-Martinez IA; Franco-Molina MA; Rivera-Morales LG; Alarcón-Galván G; Cordero-Pérez P; Rojas-Martínez A; Rodríguez-Padilla C; Muñoz-Espinosa LE
    Ann Hepatol; 2019; 18(4):620-626. PubMed ID: 31147180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial.
    Newsome PN; Fox R; King AL; Barton D; Than NN; Moore J; Corbett C; Townsend S; Thomas J; Guo K; Hull D; Beard HA; Thompson J; Atkinson A; Bienek C; McGowan N; Guha N; Campbell J; Hollyman D; Stocken D; Yap C; Forbes SJ
    Lancet Gastroenterol Hepatol; 2018 Jan; 3(1):25-36. PubMed ID: 29127060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trial: undifferentiated versus differentiated autologous mesenchymal stem cells transplantation in Egyptian patients with HCV induced liver cirrhosis.
    El-Ansary M; Abdel-Aziz I; Mogawer S; Abdel-Hamid S; Hammam O; Teaema S; Wahdan M
    Stem Cell Rev Rep; 2012 Sep; 8(3):972-81. PubMed ID: 21989829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term evaluation of autologous transplantation of bone marrow-derived mesenchymal stem cells in patients with cirrhosis: Egyptian study.
    Amin MA; Sabry D; Rashed LA; Aref WM; el-Ghobary MA; Farhan MS; Fouad HA; Youssef YA
    Clin Transplant; 2013; 27(4):607-12. PubMed ID: 23923970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of Stem Cell Transplantation Therapy for Post Viral Chronic Liver Cell Failure on Associated Type II Diabetes Mellitus: A Pilot Study.
    Haydara T; Gabr M; Abofreikha M; Bahnasy A; Salama H; Elhendawy M; Elkadeem M; Abd-Elsalam S
    Endocr Metab Immune Disord Drug Targets; 2020; 20(6):903-916. PubMed ID: 31789137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced therapeutic effects of umbilical cord mesenchymal stem cells after prolonged treatment for HBV-related liver failure and liver cirrhosis.
    Jia Y; Shu X; Yang X; Sun H; Cao H; Cao H; Zhang K; Xu Q; Li G; Yang Y
    Stem Cell Res Ther; 2020 Jul; 11(1):277. PubMed ID: 32650827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of autologous mesenchymal stem cell transplantation in patients with liver cirrhosis.
    Kantarcıoğlu M; Demirci H; Avcu F; Karslıoğlu Y; Babayiğit MA; Karaman B; Öztürk K; Gürel H; Akdoğan Kayhan M; Kaçar S; Kubar A; Öksüzoğlu G; Ural AU; Bağcı S
    Turk J Gastroenterol; 2015 May; 26(3):244-50. PubMed ID: 26006200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial.
    Kharaziha P; Hellström PM; Noorinayer B; Farzaneh F; Aghajani K; Jafari F; Telkabadi M; Atashi A; Honardoost M; Zali MR; Soleimani M
    Eur J Gastroenterol Hepatol; 2009 Oct; 21(10):1199-205. PubMed ID: 19455046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and laboratory evaluation of patients with end-stage liver cell failure injected with bone marrow-derived hepatocyte-like cells.
    Amer ME; El-Sayed SZ; El-Kheir WA; Gabr H; Gomaa AA; El-Noomani N; Hegazy M
    Eur J Gastroenterol Hepatol; 2011 Oct; 23(10):936-41. PubMed ID: 21900788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy]).
    Bartolucci J; Verdugo FJ; González PL; Larrea RE; Abarzua E; Goset C; Rojo P; Palma I; Lamich R; Pedreros PA; Valdivia G; Lopez VM; Nazzal C; Alcayaga-Miranda F; Cuenca J; Brobeck MJ; Patel AN; Figueroa FE; Khoury M
    Circ Res; 2017 Oct; 121(10):1192-1204. PubMed ID: 28974553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem cell therapy in chronic liver disease.
    Takami T; Terai S; Sakaida I
    Curr Opin Gastroenterol; 2012 May; 28(3):203-8. PubMed ID: 22395569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pooled analysis of mesenchymal stem cell-based therapy for liver disease.
    Zhao L; Chen S; Shi X; Cao H; Li L
    Stem Cell Res Ther; 2018 Mar; 9(1):72. PubMed ID: 29562935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of allogeneic mesenchymal stem cell transplantation in the treatment of liver cirrhosis caused by autoimmune diseases.
    Liang J; Zhang H; Zhao C; Wang D; Ma X; Zhao S; Wang S; Niu L; Sun L
    Int J Rheum Dis; 2017 Sep; 20(9):1219-1226. PubMed ID: 28217916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.